Author

Rony A. Francois

University of California, San FranciscoORCID 0000-0003-4699-6336Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

ADIL I. DAUDiD· 1 shared Aishwarya C. Ballapuram· 1 shared Alexandra M. Haugh· 1 shared Benjamin F. CravattiD· 1 shared Benjamin J. HuangiD· 1 shared Boer Xie· 1 shared Camille J. Leung· 1 shared Carlos GuijasiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

ADIL I. DAUDORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 20, 2025

In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer

Matthew Decker, Benjamin J. Huang, Timothy B. Ware…·Kevin Shannon

This study validates the palmitoylation cycle as a therapeutic target in NRAS-mutant cancers by showing that inhibiting ABHD17 reduces tumor growth and synergizes with MEK inhibitors.

3 citations

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyCancersPeer-reviewedMar 29, 2024

Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations

Alexandra M. Haugh, Robert C. Osorio, Rony A. Francois…·Harish N. Vasudevan

This study identifies prognostic and predictive alterations in cutaneous melanoma using targeted DNA sequencing and clinical follow-up, finding NRAS mutations correlate with worse survival and elevated TMB with better progression-free survival on combination ICI.

10 citations

humanwhole-exome sequencing

𝕏 PostBluesky